Thygeson’s Superficial Punctate Keratitis (TSPK) Disease Medical Care
Medical care for people diagnosed with Thygeson’s Superficial Punctate Keratitis (TSPK) varies depending on the severity of the condition in each individual. There are varieties of treatments that have been tried and many experimental therapies are being tested at different locations around the world. The fact is that many approaches have been taken to treat TSPK that proved to have no success at all.
In some patients, the use of antibiotics has demonstrated different levels of success. A doctor may use a series of antibiotics to determine which one achieves the best results for a particular patient. There are mixed reviews on battling TSPK with antiviral products even though Trifluridine has improved patient conditions in detectable ways. The drawback noted by some is that Trifluridine may slow the departure of the disease as opposed to when TSPK is treated with just Corticosteroids. The clinical symptoms seem to respond best to topical lubricants and provide effective relief in most patients.
Topical Corticosteroids are the mainstream treatment for TSPK even though some are guessing that it may prolong the presence of the disease. Topical Cyclosporine is believed by some doctors to be as efficient as a step-one tool against TSPK and is reported to have less negative effects on a person than Corticosteroids.
There is even a case to be made for soft contact lenses, which alleviate TSPK symptoms by working as a buffer between raised lesions and nerves on the cornea to stop friction when blinking. It is also standard procedure to prescribe anti-inflammatory medication to make TSPK patients more comfortable on a daily basis. However, there is a risk of secondary infections when using soft contact lenses.
Whenever anyone experiences any problems with their eyes or eyesight it is imperative that they contact a skilled eye doctor to determine if they need Thygeson’s Superficial Punctate Keratitis medical care.
TSPK is also known as Thygeson’s Superficial Punctate Keratopathy, Thygeson’s Disease or Thygeson’s Syndrome.
Suggested Link: http://www.molvis.org/molvis/v15/a155/mv-v15-a155-kawamoto.pdf